Stemline Therapeutics Reports Third Quarter 2017 Financial Results

November 9, 2017

NEW YORK , Nov. 09, 2017 (GLOBE NEWSWIRE)

Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing novel therapeutics for difficult to treat cancers, announced today financial results for the quarter ended September 30, 2017.

  Download the PDF Version